Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Page 1
Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells.
Cancers (Basel). 2022 Dec 16;14(24):6214. doi: 10.3390/cancers14246214.
Cancers (Basel). 2022.
PMID: 36551699
Free PMC article.
Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors.
Verdura S, Encinar JA, Teixidor E, Segura-Carretero A, Micol V, Cuyàs E, Bosch-Barrera J, Menendez JA.
Verdura S, et al.
Cancers (Basel). 2022 Dec 11;14(24):6101. doi: 10.3390/cancers14246101.
Cancers (Basel). 2022.
PMID: 36551587
Free PMC article.
Item in Clipboard
Nutritional Niches of Cancer Therapy-Induced Senescent Cells.
Llop-Hernández À, Verdura S, Cuyàs E, Menendez JA.
Llop-Hernández À, et al.
Nutrients. 2022 Sep 2;14(17):3636. doi: 10.3390/nu14173636.
Nutrients. 2022.
PMID: 36079891
Free PMC article.
Item in Clipboard
Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells.
Verdura S, Encinar JA, Fernández-Arroyo S, Joven J, Cuyàs E, Bosch-Barrera J, Menendez JA.
Verdura S, et al.
Int J Mol Sci. 2022 Sep 1;23(17):9986. doi: 10.3390/ijms23179986.
Int J Mol Sci. 2022.
PMID: 36077379
Free PMC article.
Item in Clipboard
Cite
Cite